These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37219822)
21. Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. Liao TL; Chen YM; Liu HJ; Chen DY BMJ Open; 2017 Jan; 7(1):e014032. PubMed ID: 28057661 [TBL] [Abstract][Full Text] [Related]
22. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis. Curran D; Hunjan M; El Ghachi A; El-Hahi Y; Bianco V; Ferreira G BMJ Open; 2019 Aug; 9(8):e023502. PubMed ID: 31462457 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM; Brisson M; Levin MJ Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938 [TBL] [Abstract][Full Text] [Related]
24. Direct health care costs associated with COVID-19 in the United States. DeMartino JK; Swallow E; Goldschmidt D; Yang K; Viola M; Radtke T; Kirson N J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829 [No Abstract] [Full Text] [Related]
25. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database. Bhowmik D; Hines DM; Intorcia M; Wade RL J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States. Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049 [TBL] [Abstract][Full Text] [Related]
27. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285 [TBL] [Abstract][Full Text] [Related]
28. Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States. Jain SS; Li SS; Xie J; Sutton MB; Fine JT; Edelberg JM; Gao W; Spertus JA; Cohen DJ J Med Econ; 2021; 24(1):1115-1123. PubMed ID: 34493144 [TBL] [Abstract][Full Text] [Related]
29. Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis. Schultz NM; Penson DF; Wilson SD; Song Y; Yang H; Ramaswamy K; Lowentritt B J Manag Care Spec Pharm; 2019 Aug; 25(8):889-897. PubMed ID: 31172866 [TBL] [Abstract][Full Text] [Related]
30. Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis. Strand V; Tundia N; Song Y; Macaulay D; Fuldeore M J Manag Care Spec Pharm; 2018 Apr; 24(4):344-352. PubMed ID: 29578852 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors. Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419 [TBL] [Abstract][Full Text] [Related]
32. Economic burden of herpes zoster among skilled nursing facility residents in the United States. Ma L; White RR; Narayanan S; Schmader KE J Am Med Dir Assoc; 2012 Jan; 13(1):54-9. PubMed ID: 21450176 [TBL] [Abstract][Full Text] [Related]
33. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA Arthritis Rheum; 2007 Dec; 57(8):1431-8. PubMed ID: 18050184 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044 [TBL] [Abstract][Full Text] [Related]
35. The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy. Matthews S; De Maria A; Passamonti M; Ristori G; Loiacono I; Puggina A; Curran D Open Forum Infect Dis; 2019 Feb; 6(2):ofz007. PubMed ID: 30793003 [TBL] [Abstract][Full Text] [Related]
36. Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States. Li Q; Chen SY; Burstin SJ; Levin MJ; Suaya JA Open Forum Infect Dis; 2016 Apr; 3(2):ofw067. PubMed ID: 27419151 [TBL] [Abstract][Full Text] [Related]
37. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data. Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328 [TBL] [Abstract][Full Text] [Related]
38. Significant Associations of Neurological Complications of Herpes Zoster With Stroke in Rheumatoid Arthritis Patients. Liao TL; Lin CH; Chen HH; Chen YM; Lin CC; Chen DY J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724649 [TBL] [Abstract][Full Text] [Related]
39. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany. Ultsch B; Weidemann F; Reinhold T; Siedler A; Krause G; Wichmann O BMC Health Serv Res; 2013 Sep; 13():359. PubMed ID: 24070414 [TBL] [Abstract][Full Text] [Related]
40. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study. Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]